Mark Ensor
Impact in
- Biotechnology top 0.5%
- Cancer Research and Treatments
- Biochemistry top 2%
- Amino Acid Enzymes and Metabolism
Papers in
-
- bioluminescence and chemiluminescence research 20
- Peroxisome Proliferator-Activated Receptors 10
-
- Cell Image Analysis Techniques 7
- Co-authors
- John S. Bomalaski (10 shared papers)Mike A. Clark (10 shared papers)Frederick W. Holtsberg (9 shared papers)Hsin‐Hsiung Tai (11 shared papers)Sylvia Daunert (25 shared papers)Steven A. Curley (4 shared papers)Huiping Zhou (3 shared papers)Fengxiang Yan (1 shared paper)
- Journals
- Analytical Chemistry (5 papers)Biochemical and Biophysical Research Communications (4 papers)Analytical Biochemistry (3 papers)Biochemical Journal (3 papers)Protein Engineering Design and Selection (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mark Ensor
65 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 118
- Biotechnology 892
- Biochemistry 280
- Cancer Research 470
- Pharmacology 438
- Biophysics 126
Countries citing papers authored by Mark Ensor
This map shows the geographic impact of Mark Ensor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ensor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ensor more than expected).
Fields of papers citing papers by Mark Ensor
This network shows the impact of papers produced by Mark Ensor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ensor. The network helps show where Mark Ensor may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ensor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. | 2002 | 288 |
| 2 | 2002 | 283 | |
| 3 | 2004 | 258 | |
| 4 | 2004 | 219 | |
| 5 | 2005 | 207 | |
| 6 | 2002 | 131 | |
| 7 | 1994 | 125 | |
| 8 | 1995 | 108 | |
| 9 | 2010 | 94 | |
| 10 | 1991 | 94 | |
| 11 | 1997 | 93 | |
| 12 | 1990 | 88 | |
| 13 | 2001 | 74 | |
| 14 | 1998 | 63 | |
| 15 | Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. | 2002 | 53 |
| 16 | 1994 | 48 | |
| 17 | 2011 | 45 | |
| 18 | 2008 | 38 | |
| 19 | 1998 | 36 | |
| 20 | 2006 | 36 |
About Mark Ensor
Mark Ensor is a scholar working on Molecular Biology, Biophysics, Pharmacology, Physiology and Biotechnology, having authored 67 papers that have together received 3.1k indexed citations. Recurring topics across this work include bioluminescence and chemiluminescence research (20 papers), Peroxisome Proliferator-Activated Receptors (10 papers), Inflammatory mediators and NSAID effects (10 papers), Biosensors and Analytical Detection (9 papers), Cancer Research and Treatments (7 papers), Cell Image Analysis Techniques (7 papers), Adenosine and Purinergic Signaling (6 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Biotechnology (892 citations), Biochemistry (280 citations), Cancer Research (470 citations), Pharmacology (438 citations) and Biophysics (126 citations). Mark Ensor has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John S. Bomalaski, Mike A. Clark, Frederick W. Holtsberg, Hsin‐Hsiung Tai, Sylvia Daunert, Steven A. Curley, Huiping Zhou, Fengxiang Yan, Min Tong and Hsin-Hsiung Tai. Their work appears in journals such as Analytical Chemistry, Biochemical and Biophysical Research Communications, Analytical Biochemistry, Biochemical Journal and Protein Engineering Design and Selection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.